Watchlist Price Alert

Lineage Cell Therapeutics... (LCTX)

AMEX: LCTX · Real-Time Price · USD

0.82

-0.04 (-5.18%)

At close: Jun 17, 2025, 10:53 AM

Lineage Cell Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	45.79M	35.44M	11.36M	55.74M	32.59M	9.5M	23.59M	36.84M	22.09M
Short-Term Investments	2.02M	50K	46.52M	2.62M	8.98M	21.22M	7.15M	1.34M	627K
Long-Term Investments	n/a	n/a	581K	535K	520K	100K	33.73M	117.17M	100.04M
Other Long-Term Assets	614K	577K	627K	630K	616K	864K	505K	1.02M	1.03M
Receivables	638K	745K	297K	50.84M	4K	23.94M	3.72M	3.05M	1.16M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.55M	2.2M	1.83M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	51M	38.44M	60M	111.55M	44M	57.52M	36.36M	42.62M	25.65M
Property-Plant & Equipment	4.39M	4.77M	5.67M	4.87M	5.63M	8.18M	5.83M	5.53M	5.53M
Goodwill & Intangibles	57.21M	57.23M	57.36M	57.49M	57.7M	58.92M	3.13M	6.9M	10.21M
Total Long-Term Assets	62.22M	62.58M	63.66M	63M	63.95M	67.96M	65.3M	130.62M	116.92M
Total Assets	113.22M	101.02M	123.66M	174.54M	107.95M	125.48M	101.66M	173.24M	142.57M
Account Payables	1.17M	2.05M	2.39M	3.54M	2.61M	2.43M	2.36M	938K	1.59M
Deferred Revenue	7.39M	10.81M	9.42M	18.12M	193K	45K	42K	797K	572K
Short-Term Debt	1.15M	882K	n/a	n/a	762K	1.22M	70K	152K	932K
Other Current Liabilities	1.2M	1.1M	3.83M	22.46M	1.73M	660K	1.65M	2.5M	3.65M
Total Current Liabilities	13.98M	17.96M	18.98M	47.12M	7.77M	6.49M	6.81M	6.88M	8.85M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	18K	1.15M
Other Long-Term Liabilities	6.16M	n/a	2K	30K	437K	277K	644K	930K	58K
Total Long-Term Liabilities	22.23M	21.04M	32.75M	36.53M	5.05M	7.74M	2.6M	2.1M	3.21M
Total Liabilities	36.21M	39M	51.73M	83.65M	12.82M	14.23M	9.41M	8.98M	12.06M
Total Debt	2.51M	2.95M	3.9M	2.8M	3.3M	5.17M	2.27M	1.53M	3.98M
Common Stock	484.72M	451.34M	440.28M	434.53M	393.94M	387.06M	354.27M	378.49M	317.88M
Retained Earnings	-403.46M	-384.86M	-363.37M	-337.1M	-294.08M	-273.42M	-261.86M	-216.3M	-196.32M
Comprehensive Income	-2.88M	-3.07M	-3.57M	-5.21M	-3.67M	-681K	1.43M	451K	-738K
Shareholders Equity	78.38M	63.42M	73.34M	92.22M	96.2M	112.96M	93.84M	162.64M	117.93M
Total Investments	2.02M	50K	46.52M	2.62M	8.98M	21.22M	40.89M	118.5M	100.67M